Šalis: Europos Sąjunga
kalba: lietuvių
Šaltinis: EMA (European Medicines Agency)
recombinant human interferon alfa-2a
BioPartners GmbH
L03AB04
interferon alfa-2a
Immunostimulants,
Hepatitas C, lėtinis
Adult patients with histologically proven chronic hepatitis C who are positive for hepatitis C virus (HCV) antibodies or HCV RNA and have elevated serum alanine aminotransferase (ALT) without liver decompensation. The efficacy of Interferon alfa-2a in the treatment of hepatitis C is enhanced when combined with ribavirin. Alpheon should be given alone mainly in case of intolerance or contra-indication to ribavirin.
Atsisakyta